Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy

Clinical Endocrinology

Volumn 52, Issue 1, 2000, Pages 1-9

  Janssen, J A M J L ^a,b   Lamberts, S W J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

AGE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE BLOOD LEVEL; MICROANGIOPATHY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ADOLESCENT; ADULT; AGED; AGING; ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED;

EID: 0033977868     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.00922.x     Document Type: Review

References (102)

1. Acerini, C.L., Clayton, K.L., Hintz, R., Baker, B., Watts, A., Holly, J.M. & Dunger, D.B. (1996) Serum insulin-like growth factor II levels in normal adolescents and those with insulin dependent diabetes. Clinical Endocrinology, 45, 13-19.
2. Acerini, C.L., Patton, C.M., Savage, M.O., Kernell, A., Westphal, O. & Dunger, D.B. (1997) Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. Lancet, 350, 1199-2004.
3. Alder, V.A., Su, E.N., Yu, D.Y., Cringle, S.J. & Yu, P.K. (1997) Diabetic retinopathy: early functional changes. Clinical and Experimental Pharmacology and Physiology, 24, 785-788.
4. Anonymous (1993) The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977-986.
5. Anonymous (1998). The Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Archives of Ophtalmology, 116, 874-886.
6. Averbukh, E., Weiss, O., Halpert, M., Yanko, R., Moshe, R., Nepesh, I., Flyvbjerg, A., Yanko, L. & Raz, I. (1998) Gene expression of insulin-like growth factor I, its receptor and binding proteins in retina under hypoxic conditions. Metabolism, 47, 1331-1336.
7. Bang, P., Brismar, K. & Rosenfeld, R.G. (1994) Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130-to 150-kDa ternary complex. Journal of Clinical Endocrinology and Metabolism, 78, 1119-1127.
8. Brown, M., Ahmed, M.L., Clayton, K.L. & Dunger, D.B. (1994) Growth during childhood and final height in type I diabetes. Diabetic Medicine, 111, 182-187.
9. Brown, D.L., Kane, C.D., Chernausek, S.D. & Greenhalgh, D.G. (1997) Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic and nondiabetic mice. American Journal of Pathology, 151, 715-724.
10. Carroll, P.V., Umpleby, M., Ward, G.S., Imuere, S., Alexander, E., Dunger, D., Sonken, P.H. & Russell-Jones, D.L. (1997) rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults in IDDM. Diabetes, 46, 1453-1458.
11. Chantelau, E. & Kohner, E.M. (1997) Why some cases of retinopathy worsen when diabetic control improves. British Medical Journal, 315, 1105-1106.
12. Chapman, I.M., Hartman, M.L., Pieper, K.S., Skiles, E.H., Pezzoli, S.S., Hintz, R.L. & Thorner, M.O. (1998) Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I. Journal of Clinical Endocrinology and Metabolism, 83, 2836-2843.
13. Cheetham, T.D., Connors, M., Clayton, K., Watts, A. & Dunger, D.B. (1997) The relationship between overnight GH levels and insulin concentrations in adolescents with insulin-dependent diabetes mellitus (IDDM) and the impact of recombinant human insulin-like growth factor I (rhIGF-I). Clinical Endocrinology, 46, 415-424.
14. Chen, M., Bergman, R.N., Pacini, G. & Porte, D. Jr (1985) Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. Journal of Clinical Endocrinology and Metabolism, 60, 13-20.
15. Clauson, P.G., Brismar, K., Hall, K., Linnarson, R. & Grill, V. (1998) Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden. Scandinavian Journal of Clinical and Laboratory Investigation, 58, 353-360.
16. Clemmons, D.R. (1997) Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine and Growth Factor Reviews, 8, 45-62.
17. Clemmons, D.R., Moses, A.C., Sommer, A., McKay, M.C., Rosen, D. & Ruckle, J. (1999) The combination of IGF-I and IGFBP-3 enhances insulin sensitivity in type I diabetes mellitus. 81th Annual Meeting of the Endocrine Society, San Diego, (June 12-15), Abstract.
18. Collet-Solberg, P.F. & Cohen, P. (1996) The role of insulin-like growth factor binding proteins and the IGFBP proteases in modulation of IGF action. Endocrinology and Metabolism Clinics of North America, 25, 519-614.
19. Cooppan, R. (1994) General approach to the treatment of diabetes. In: Joslin's Diabetes Mellitus (eds C. R. Kahn & G. C. Weir), pp. 399. Lea & Febiger, Philadelphia.
20. Crosby, S.R., Tsigos, C., Anderton, C.D., Gordon, C., Young, R.J. & White, A. (1992) Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy. Diabetologia, 35, 868-872.
21. Cusi, K. & DeFronzo, R. (1995) Treatment of NIDDM, IDDM and other insulin resistant states with IGF-I. Diabetes Reviews, 3, 206-236.
22. Davis, M.D. & Rand, L.I. (1992) Diabetic retinopathy. In: International Textbook of Diabetes Mellitus (eds K. G. M. M. Alberti, R. A. Defronzo, H. Keen & P. Zimmet), pp. 1348. John Wiley & Sons, Chicester.
23. Davis, M.D. (1998) Worsening of diabetic retinopathy after improvement of glycemic control. Archives of Ophthalmology, 116, 931-932.
24. Ditzel, J. (1980) Affinity hypoxia as a pathogenetic factor of microangiopathy with particular reference to diabetic retinopathy. Acta Endocrinologica, 238 (Suppl.), 39-55.
25. Doi, T., Striker, L.J., Quaife, C., Conti, F.G., Palmiter, R., Behringer, R., Brinster, R. & Striker, G.E. (1988) Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulin-like growth factor-I. American Journal of Pathology, 131, 398-403.
26. 3H] thymidine uptake in bovine retinal pericytes and endothelial cells. Acta Diabetologia, 30, 207-213.
27. Dunger, D.B., Cheetham, T.D. & Crowne, E.C. (1995) Insulin-like growth factors (IGFs) and IGF-I treatment in the adolescent with insulin-dependent diabetes mellitus. Metabolism, 44 (Suppl.), 119-123.
28. Eskildsen, P.C., Parving, H.-H., Mogensen, C.E. & Christiansen, J.S. (1979) Kidney function in acromegaly. Acta Medica Scandinavica, 624 (Suppl.), 79-82.
29. Flier J.S. & Moses, A.C. (1989) Diabetes in acromegaly and other endocrine disorders. In: Endocrinology, Vol. 2, (ed. L. J. DeGroot), pp. 1389-1399, W.B. Saunders, Philadelphia.
30. Flynn, M.D., O'Brien, I.A. & Corall, R.J. (1995) The prevalence of autonomic and peripheral neuropathy in diabetic subjects. Diabetic Medicine, 12, 310-312.
31. Flyvbjerg, A., Thorlacius-Ussing, O., Naeraa, R., Ingerslev, J. & Ørskov, H. (1988) Kidney tissue somatomedin C and initial retinal growth in diabetic and uninephrectomized rats. Diabetologia, 31, 310-314.
32. Flyvbjerg, A., Frystyk, J., Thorlacius-Ussing, O. & Ørskov, H. (1989) Somatostatin analogue prevents increase in kidney somatomedin C and initial growth in diabetic and uninephrectomized rats. Diabetologia, 32, 261-265.
33. Flyvbjerg, A. (1990) Growth factors and diabetic complications. Diabetic Medicine, 7, 387-399.
34. Flyvbjerg, A., Bornfeldt, K.E., Ørskov, H. & Arnqvist, H.J. (1991) Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes mellitus in rats. Diabetologia, 34, 715-720.
35. Flyvbjerg, A., Marshall, S.M., Frystyk, J., Hansen, K.W., Harris, A.G. & Ørskov, H. (1992) Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion. Kidney International, 41, 805-812.
36. Flyvbjerg, A., Bennett, W., Rasch, R., Kopchick, J.J. & Scarlett, J.A. (1999) Inhibitory effect of frowth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. Diabetes, 48, 377-382.
37. Froesch, E.R. (1997) Insulin-like growth factor: endocrine and autocrine/paracrine implications and relations to diabetes mellitus. In: Contributions of Physiology to the Understanding of Diabetes. Ten Essays in Memory of Albert E. Renold (eds G.R. Zahnd & C.B. Wollheim), pp. 127-147, Springer-Verlag, Berlin.
38. Frystyk, J., Skjærbæk, C., Dinesen, B. & Ørskov, H. (1994) Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Letters, 348, 185-191.
39. Giannini, S., Cresci, B., Manuelli, C., Fujita-Yamaguchi, Y., Romagnani, P., Mohan, S. & Rotella, C.M. (1997) Insulin-like growth factor binding protein production in bovine retinal endothelial cells. Metabolism, 46, 1367-1379.
40. Gibson, J.M., Westwood, M., Lauszus, F.F., Klebe, J.G., Flyvbjerg, A. & White, A. (1999) Phosphorylated insulin-like growth factor binding protein I is increased in pregnant diabetic subjects. Diabetes, 48, 321-326.
41. Grant, M.B., Mames, R.N., Fitzgerald, C., Ellis, E.A., Aboufriekha, M. & Guy, J. (1993a) Insulin-like growth factor-I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor. Diabetologia, 36, 282-291.
42. Grant, M.B., Caballero, S. & Millard, W.J. (1993b) Inhibition of IGF-I and bFGF stimulated growth of human retinal endothelial cells by the analogue, octreotide. A potential treatment for ocular neovascularization. Regulatory Peptides, 48, 267-278.
43. Greenspan, S.L. & Resnick, N.M. (1997) Geriatric endocrinology. In: Basic and Clinical Endocrinology (eds F.S. Greenspan & G.J. Strewler), pp. 770-787. Prentice Hall International Inc, Stamford.
44. Grønbaek H., Volmers P., BjØrn S.F., Østerby R., Ørskov H. & Flyvbjerg A. (1997) Effect of GH/IGF-I deficiency on long-term renal changes and urinary albumin excretion in diabetic dwarf rats. American Journal of Physiology, 272, E918-E924.
45. Gumbiner, B., Polonsky, K.S., Beltz, W.F., Wallace, P., Brechtel, G. & Fink, R.I. (1989) Effects of aging on insulin secretion. Diabetes, 38, 1549-1556.
46. Harris A., Arend O., Danis R.P., Evans D., Wolf S., Martin B.J. (1996) Hyperoxia improves contrast sensitivity in early diabetic retinopathy. British Journal of Ophthalmology, 80, 209-213.
47. He, C.J., Striker, L.J., Tsokos, M., Yang, C.W. & Striker, G.E. (1995) Relationships between mesangial cell proliferation and types I and IV collagen mRNA levels in vitro. American Journal of Physiology, 269, C554-C562.
48. Hellstrõm, A., Svensson, E., Carlsson, B., Niklasson, A. & Albertsson-Wikland, K. (1999) Reduced retinal vacularization in children with growth hormone deficiency. Journal of Clinical Endocrinology & Metabolism, 84, 795-798.
49. Hirschberg, R. & Kopple, J.D. (1993) The effects of growth hormone and insulin-like growth factor I on renal glomerular and tubular function. In: Growth Hormone and Insulin-Like Growth Factor I in Human and Experimental Diabetes (eds A. Flyvbjerg, H. Ørskov, K.G.M.M. Alberti), pp. 229-254, John Wiley & Sons, Chichester.
50. Holly, J.M.P., Biddlecombe, R.A., Dunger, D.B., Edge, J.A., Amiel, S.A., Howell, R., Chard, T., Rees, L.H. & Wass, J.A. (1988) Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin?. Clinical Endocrinology, 29, 667-675.
51. Ishii, D.N. (1994) Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Research Reviews, 20, 47-67.
52. Janssen, J.A.M.J.L., Jacobs, M.L., Derkx, F.H.M., Weber, R.F.A., Van der Lely, A.J. & Lamberts, S.W.J. (1997) Free and total insulin-like growth factor I (IGF-I), IGF-binding protein (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 82, 2809-2815.
53. Janssen, J.A.M.J.L. & Lamberts, S.W.J. (1999) Is the measurement of free IGF-I more indicative than that of total IGF-Iin the evaluation of the biological activity of the GH/IGF-I axis? Journal of Endocrinological Investigation, 22, 313-315.
54. Jones, J.I., D'Ercole, A.J., Camacho-Hubner, C. & Clemmons, D.R. (1991) Phosphorylation of insulin-like growth factor (IGF) -binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proceedings of the National Academy of Sciences of the United States of America, 88, 7481-7485.
55. Juul, A. (1995) Serum levels of IGF-I and IGFBP-3 in healthy children, adolescents and adults. Methodological aspects and definition of reference values with special emphasis on puberty. PhD Thesis, Department of Growth and Reproduction, University of Copenhagen.
56. Juul, A., Holm, K., Kastrup, K.W., Pedersen, A., Fleischer Michaelsen, K., Scheike, T., Rasmussen, S., Müller, J. & Skakkebæk, N.E. (1997) Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 82, 2497-2502.
57. Kiess, W., Kapellen, T., Siebler, T., Dost, A., Deutscher, J. & Nietzschmann, U. (1998) Improvements and new potentials in pharmacological therapy of diabetes mellitus in children and adolescents. Hormone Research, 50 (Suppl), 87-90.
58. King, G.L., Goodman, A.D., Buzney, S., Moses, A. & Kahn, C.R. (1985) Receptors and growth promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. Journal of Clinical Investigation, 75, 1028-1036.
59. Klein, R., Klein, B.E. & Moss, S.E. (1985) A population-based study of diabetic retinopathy in insulin-using patients diagnosed before 30 years of age. Diabetes Care, 8 (Suppl.), 71-76.
60. Klein, B.E., Linfoot, J.A., Nakagawa, J.S. & Lee, K.E. (1998) Survival following alpha particle pituitary irradiation for diabetic retinopathy. Journal of Diabetes Complications, 12, 246-251.
61. Kohner, E.M., Joplin, G.F., Black, R.K., Cheng, H. & Fraser, T.R. (1972) Pituitary ablation in the treatment of diabetic retinopathy. Transactions of the Ophtalmological Societies of the United Kingdom, 92, 79-90.
62. Knuiman, M.W., Welborn, T.A., McCann, V.J., Stanton, K.G. & Constable, I.J. (1986) Prevalence of diabetic complications in relation to risk factors. Diabetes, 35, 1332-1339.
63. Krolewski, A.S., Warram, J.H. & Freire, M.B. (1996) Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs. Endocrinology and Metabolism Clinics of North America, 25, 217-242.
64. Landau, D., Chin, E., Bondy, C., Domene, H., Roberts, C.T. Jr, Gronbaek, H., Flyvbjerg, A. & LeRoith, D. (1995) Expression of insulin-like growth factor binding proteins in the kidney: effects of long-term diabetes. Endocrinology, 136, 1835-1842.
65. Lewitt, M.S., Denyer, G.S., Cooney, G.J. & Baxter, R.C. (1991) Insulin-like growth factor binding protein-1 modulates blood glucose levels. Endocrinology, 129, 2254-2256.
66. Luetkke, B., Lang, G.E., Lang, G.K. & Boehm, B.O. (1998) Association of diabetic retinopathy with diminished levels of free IGF-I. 80th Annual Meeting of the Endocrine Society, New Orleans, (June 24-27), Abstract P3-353.
67. Lundbaek, K., Malmros, R. & Andersen, H.C. (1969) Hypophysectomy for diabetic retinopathy: a controlled clinical trial. In: Symposium on the Treatment of Diabetic Retinopathy, Airlie House, Warrington, Virginia, September 29-October 1, 1968 (eds M.F. Goldberg & S.L. Fine), pp. 291-311, US Government Printing Office, Washington DC.
68. Merimee, T.J., Fineberg, S.E., McKusick, V.A. & Hall, J. (1970) Diabetes mellitus and sexual ateliotic dwarfism: a comparative study. Journal of Clinical Investigation, 49, 1096-1102.
69. Merimee, T.J., Zapf, J. & Froesch, E.R. (1983) Insulin-like growth factors: studies in diabetics with and without retinopathy. New England Journal of Medicine, 309, 527-530.
70. Merimee, T.J. (1990) Diabetic retinopathy: a synthesis of perspectives. New England Journal of Medicine, 322, 978-983.
71. Merimee, T.J. (1997) The interface between diabetic retinopathy, diabetes management, and insulin-like growth factors. Journal of Clinical Endocrinology and Metabolism, 82, 2806-2807.
72. Mitchell, P. (1997) Cancelled IGF-I trials bode ill for diabetic patients. Lancet, 350, 1606.
73. Mizutani, M., Kern, T.S. & Lorenzi, M. (1996) Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. Journal of Clinical Investigation, 97, 2883-2890.
74. Mogensen, C.E. (1994) Glomerular hyperfiltration in diabetes. Diabetes Care, 17, 770-775.
75. Møller, N. & Ørskov, H. (1997) Does IGF-I therapy in insulin-dependent diabetes mellitus limit complications? Lancet, 350, 1188-1189.
76. Moses A.C., Young S.C., Morrow L.A., O'Brien M. & Clemmons D.R. (1996) Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes, 45, 91-100.
77. Moses, A.C. (1997) Recombinant insulinlike growth factor-I as therapy in states of altered carbohydrate homeostasis. Current Opinion in Endocrinology and Diabetes, 4, 16-25.
78. Pfeiffer, A., Spranger, J., Meyer-Schwickerath, R. & Schatz, H. (1997) Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Diabetes, 46 (Suppl.), S26-S30.
79. Poulsen, J.D. (1966) Diabetes and anterior pituitary deficiency: final course and postmortem study of a diabetic patient with Sheehan's syndrome. Diabetes, 15, 73-77.
80. Quattrin, T., Thrailkill, K., Baker, L., Litton, J., Dwigun, K., Rearson, M., Poppenheimer, M., Giltinan, D., Gesundheit, N. & Martha, P. Jr (1997) Dual hormonal replacement with insulin and recombinant human insulin like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile. Diabetes Care, 20, 374-380.
81. Rabkin, R. (1995) Insulin-like growth factor-I treatment of acute renal failure. Journal of Laboratory and Clinical Medicine, 125, 684-685.
82. Robinson Singleton, J., Dixiit, V.M. & Feldman, E.L. (1996) Type I insulin-like growth factor receptor activation regulates apoptotic proteins. Journal of Biological Chemistry, 271, 31791-31794.
83. Russell, J.W. & Feldman, E.L. (1996) Insulin-like growth factor-I (IGF-I) protects neurons from glucose-induced cell death. Diabetologia, 39 (Suppl. 1), Abstract 16.
84. Rutanen, E.M., Karkkainen, T., Stenman, U.H. & Yki-Jarvinen, H. (1993) Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. Journal of Clinical Endocrinology and Metabolism, 77, 1152-1155.
85. Sharp, P.S., Fallon, T.J., Brazier, O.J., Sandler, L., Joplin, G.F. & Kohner, E.M. (1987) Longterm follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy. Diabetologia, 30, 199-207.
86. Sharp, P.S. (1993) Diabetic retinopathy: an analysis of the possible pathogenic roles of growth hormone and insulin-like growth factor I. In: Growth Hormone and Insulin-Like Growth Factor I in Human and Experimental Diabetes (eds A. Flyvbjerg, H. Ørskov, K.G.M.M. Alberti), pp. 202-228. John Wiley & Sons, Chichester.
87. Simpson, H.L., Umpleby, A.M. & Russell-Jones, D.L. (1998) Insulin-like growth factor-I and diabetes. A review. Growth Hormone and IGF Research, 8, 83-95.
88. Schmetterer, L. & Wolzt, M. (1999) Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia, 42, 387-405.
89. Schmitz, A. (1992) The kidney in non-insulin-dependent diabetes: studies on glomerular structure and function and the relationship between microalbuminuria and mortality. Acta Diabetologica, 29, 47-69.
90. Seyer-Hansen, K. (1987) Renal hypertrophy in experimental diabetes: some functional effects. Journal of Diabetic Complications, 1, 7-10.
91. Smith, L.E.H., Weslowski, E., McLellan, A., Kostyk, S.K., D'Amato, R., Sullivan, R. & D'Amore, P.A. (1994) Oxygen-induced retinopathy in the mouse. Investigative Ophtalmology and Visual Science, 35, 101-111.
92. Smith, L.E.H., Kopchick, J.J., Chen, W., Knapp, J., Kinose, F., Daley, D., Foley, E., Smith, R.G. & Schaeffer, J.M. (1997) Essential role of growth hormone in ischemia-induced retinal neovascularization. Science, 276, 1706-1709.
93. Spoerri, P.E., Ellis, E.A., Tarnuzzer, R.W. & Grant, M.B. (1998) Insulin-like growth factor: receptor and binding proteins in human retinal endothelial cell cultures of diabetic and non-diabetic origin. Growth hormone and IGF Research, 8, 125-132.
94. Tan, K. & Baxter, R.C. (1986) Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age. Journal of Clinical Endocrinology and Metabolism, 63, 651-655.
95. Taylor, A.M., Dunger, D.B., Preece, M.A., Holly, J.M.P., Smith, C.P., Wash, J.A.H., Patel, S. & Tate, V.E. (1990) The growth hormone independent insulin-like growth factor-I binding protein BP-28 is associated with serum insulin-like growth factor I inhibitory bioactivity in adolescent insulin dependent diabetes. Clinical Endocrinology, 32, 229-239.
96. Waldbillig, R.J., Jones, B.E., Schoen, T.J., Moshayedi, P., Heidersbach, S., Bitar, M.S., van Kuijk, F.J., de Juan, E., Kador, P. & Chader, G.J. (1994) Vitreal insulin-like growth factor binding proteins (IGFBPs) are increased in human and animal diabetics. Current Eye Research, 13, 539-546.
97. Wang, Q., Dills, D.G., Klein, R., Klein, B.E.K. & Moss, S.E. (1995) Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy. Diabetes, 44, 161-164.
98. Werner, H., Shen-Orr, Z., Stannard, B., Burguera, B., Roberts, C.T. & LeRoith, D. (1990) Experimental diabetes increases insulinlike growth factor I and II receptor concentration and gene expression in the kidney. Diabetes, 39, 1490-1497.
99. Winegrad, A.I., Simmons, D.A. & Martin, D.B. (1983) Has one diabetic complication been explained. New England Journal of Medicine, 308, 152-154.
100. Young, R.J., Macintyre, C.C.A., Martyn, C.N., Prescott, R.J., Ewing, D.J., Smith, A.F., Viberti, G. & Clarke, B.F. (1986) Progression of subclinical polyneuropathy in young patients with type I (insulin-dependent) diabetes: associations with glycaemic control and microangiopathy (microvascular complications). Diabetologia, 29, 156-161.
101. Young, M.J., Boulton, A.J., Macleod, A.F., Williams, D.R. & Sonksen, P.H. (1993) A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia, 36, 150-154.
102. Zhuang, H.-X., Snyder, C.K., Pu, S.-F. & Ishii, D.N. (1996) Insulin-like growth factors reverse or arrest diabetic neuropathy: effects on hyperalgesia and impaired nerve regeneration in rats. Experimental Neurology, 140, 198-205.